|
|
|
Heber Biotec S.A. is the commercializing company from CIGB. The company
owns the exclusive rights for the commercialization of the CIGB's products
and projects, and has developed fruitful business relationships with companies
and institutions in more than 50 countries. The CIGB's leader products
are recombinant Hepatitis B Vaccine (HEBERVIOCAC-HB®), recombinant
alpha 2b Interferon(HEBERON ALPHA R®), recombinant Streptokinase (HEBERKINASE®),
Interferon gamma (HEBERON GAMMA®), Epidermal Growth Factor (HEBERMIN®),
Erythropoietin (HEBERITRO®), recombinant GSCF (HEBERVITAL®), Hib
preventive synthetic vaccine (Quimi-Hib®), combined vaccine Trivac-HB®,
and Vaccine for the control of cattle tick (GAVAC®).
|
|
 |
|
